BioStem Technologies Announces Filing of Restated Financial Statements

BioStem Technologies Announces Filing of Restated Financial Statements

Key Takeaways Restated Financials Filed — BioStem filed restated interim and annual financial statements for 2023–2025, aligning with US GAAP for revenue recognition. Revenue Classification Update — Bona fide services fees from Venture Medical are now treated as...

VAYK Reported $1.5 Million Q3 Revenue & Outlined Crypto Strategy

VAYK Reported $1.5 Million Q3 Revenue & Outlined Crypto Strategy

Key Takeaways Strong Financial Growth — Great Estate Blockchain (OTC: VAYK) reported $1.5M revenue and $350K operating profit for the first three quarters of 2025, a 300% YoY increase. Blockchain-Powered Real Estate Model — The firm will issue crypto tokens...